Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from OrganiGram Holdings ( (TSE:OGI) ) is now available.
Organigram has entered into a subscription agreement with BT DE Investments, a subsidiary of British American Tobacco, for a C$65.2 million private placement linked to its planned acquisition of German cannabis operator Sanity Group. BAT will subscribe for over 23.9 million Organigram shares at prices tied to both the Sanity transaction and existing top-up rights, with a mix of common and non-voting preferred shares structured to cap its voting stake at 30%.
The funding, together with existing cash and a previously arranged senior secured credit facility of up to $60 million, will finance the cash portion of the Sanity acquisition, transaction costs and general working capital, underscoring Organigram’s push into the European cannabis market. The deal remains contingent on closing the Sanity acquisition, shareholder approval from disinterested investors, TSX and regulatory clearances, and highlights BAT’s deepening strategic and financial role as an insider stakeholder in Organigram.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$4.00 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is held back primarily by weak operating profitability and negative cash flow despite revenue growth, reinforced by bearish technicals (below key moving averages and negative MACD). A low-leverage balance sheet and a moderate P/E provide partial support but are not enough to offset the core earnings and cash-flow risks.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a Canada-based global cannabis company listed on Nasdaq and the TSX, focused on producing and marketing cannabis products. The company operates in both domestic and international markets and is expanding its footprint through strategic acquisitions and partnerships, including ties with major consumer goods players such as British American Tobacco.
Average Trading Volume: 348,303
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$236.5M
See more insights into OGI stock on TipRanks’ Stock Analysis page.
